An aging population and better long-term diabetes treatment options mean more people with diabetes are living longer. Seniors with a long duration of diabetes are at high risk for hypoglycemia and hypoglycemia unawareness. Is real-time continuous glucose monitoring (rtCGM) a realistic option? Dr. Pratley will review the WISDM trial and share case examples to highlight the benefits and barriers to rtCGM use in older people with diabetes.

Dr. Richard E. Pratley, MD

Medical Director at the AdventHealth Diabetes Institute
Senior Investigator, Diabetes Program Lead at the Translational Research Institute

Richard Pratley serves as the Samuel E. Crockett Chair in Diabetes Research, as well as Senior Investigator and Diabetes Program Lead, at the AdventHealth Translational Research Institute and Medical Director at the AdventHealth Diabetes Institute, both in Orlando, Florida… View Speaker’s Full Bio